跳至主要内容
临床试验/NCT05413681
NCT05413681招募中不适用

Metabolomic Approach During Exercise Testing in Myalgia Induced by eXercise

University Hospital, Clermont-Ferrand1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2022年10月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
150
试验地点
1
主要终点
Metabolomic response profile mesuring by mass spectrometer during a supra-maximal exercise test on a cycloergometer.

研究概览

简要总结

Metabolic myopathies form a group of pathologies related to a deficit of muscle energy production (enzymatic deficit) by disorder of the metabolism of carbohydrates, lipids, purines, or mitochondrial involvement related to dysfunction of complex respiratory chain. Most often, the symptomatology may include signs of "muscular" calling with cramps, contractures or exercise myalgia, more or less associated with exercise intolerance with early fatigability and rhabdomyolysis. In practice, the clinical signs are not specific and not pathognomonic, or sometimes absent with only an isolated elevation of the CPK. The diagnosis of certainty is usually based on the realization of a muscle biopsy (invasive). Unfortunately, the performance of the biopsy (definitive diagnosis of myopathy) in front of myalgia is low, hence the interest of functional explorations upstream to better specify its indication.

Given the considerable increase in muscle metabolism to physical effort, resting investigations may not uncover myo-metabolic deficit. The muscle enzymatic deficit, is therefore most often "silent" at rest and its highlighting requires to explore the patient with effort, asking him to perform an exercise test on cycloergometer and/or an isometric contraction of the forearm ('handgrip test'). Currently, only a few metabolites are dosed before and after exertion such as lactate, pyruvic acid and ammonium. Several studies in normal subjects showed the effect of physical exercise on the metabolomic signature of plasma. Our aim is to apply modern metabolomic techniques to plasma and urinary samples collected as part of the care pathway in patients referred to in the Department of Sports Medicine-Functional Explorations of the CHU in comparison with healthy volunteers).

详细描述

Patients will be pre-selected on the basis of their medical records and control subjects will be subjected, after signing the consent form, to a medical check-up, carried out at one of the study sites, including an interrogation on personal and family history and medication taken as well as a standard medical examination.

All subjects will be checked for compliance with the inclusion/exclusion criteria during this visit.

The subjects (patients and controls) will arrive in the morning on an empty stomach at the Sports Medicine Department of the Clermont-Ferrand University Hospital or at the Human Nutrition Unit for healthy volunteers. The subjects will be questioned about their personal and family history, about any medication they are taking, and their height and weight will be measured. The subjects will meet with a dietician to review their diet over the past 24 hours. A urine sample will be collected and divided into two aliquots: one for urinary organic acid chromatography (routine care) and one for storage for later metabolomics, transcriptomics and genomics.

Blood samples (n = 120) will be taken at the same times as during their usual care, before, during and during recovery from exercise: at rest, after the 3 maximal forearm contractions, at 1 minute of recovery from the 30-second grip-test contraction effort, before the exercise test on a cycloergometer, 2 samples during exercise on a cycloergometer (mid 'threshold' and peak of the effort), 2 samples during recovery from exercise on a cycloergometer (at 2 and 10 minutes), and 1 sample at 24 hours.

Patients will be offered to take this sample, 24 hours after the exercise test, at the Nutritional Testing Unit of the CRNH A or in their usual laboratory. If patients come to the Nutritional Testing Unit of the CRNH A for this blood test, the patients will be offered to measure their maximal muscular oxidative capacity (mVO2), using optical measurement of muscle oxygenation (near infrared spectroscopy, NIRS). If the patients do not return to the Nutritional Investigation Unit of the CRNH A for the 24-hour blood test, this measurement of maximal muscular oxidative capacity will be performed during their medical consultation to inform them of the results of their metabolic stress test (approximately 1 month later).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • For patients:
  • Patient, male or female, adult or minor aged 15 years or more, referred to the Sports Medicine Department of the Clermont-Ferrand University Hospital for metabolic exploration during exercise, as part of the diagnostic work-up for one of the following clinical contexts:
  • Suspicion of metabolic myopathy
  • Cramps, contractures or myalgias during or after exercise
  • Exercise intolerance/fatigability without obvious cause (cardiac and/or respiratory etiology in particular)
  • Episode of malignant hyperthermia or rhabdomyolysis during exercise
  • Unexplained elevation of CPK
  • For healthy subjects:
  • Major subject, male or female, 18 to 50 years old.
  • No chronic pathology
  • No treatment (background or at the time of the examination)
  • Non-smoker
  • No/little alcohol consumption (<5 glasses/week), no consumption in the 48 hours before the stress test
  • Non/little athletic (<2h of strenuous physical activity/week), no physical activity the day before and the day of (pre- and post-test)
  • For all participants:
  • Able to give informed consent to participate in the research
  • For minor patients, consent from the holders of parental authority
  • Affiliation to the French Social Security system

排除标准

  • For healthy subjects:
  • Refusal of registration in the national file of volunteers for research involving the human person.
  • Subject in a period of exclusion from a previous study or having received a total amount of compensation greater than 4500 euros over the 12 months preceding the start of the trial (after verification in the File of Volunteers for Research Involving the Human Person).
  • For all participants:
  • Contraindications to an exercise test on a cycloergometer, mainly cardiorespiratory (ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respi Care Med. 2003;167:211-77.)
  • Pregnant women (a pregnancy test will be performed on all participants of childbearing age on the day the exercise tests are performed) and nursing mothers.
  • Refusal to sign the consent form.
  • Patients under guardianship, curatorship, deprived of liberty or safeguard of justice.

结局指标

主要结局

Metabolomic response profile mesuring by mass spectrometer during a supra-maximal exercise test on a cycloergometer.

时间窗: 24 hours after effort test

blood samples will be taken : before the exercise test on the cycloergometer, 2 samples during exercise on the cycloergometer (middle of the threshold and peak of the exercise), 2 samples during recovery from exercise on the cycloergometer (at 2 and 10 minutes), and 1 sample at 24 hours

次要结局

  • Metabolomic response profile mesuring by mass spectrometer to a handgrip muscle activity test.(5 minutes after grip-test)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

招募中
不适用
Metabolic Exercise TestingMetabolic MyopathiesExercise TestMyalgia
NCT02362685University Hospital, Brest1,000
Unknown
不适用
Fat and Sugar Metabolism During Exercise in Patients With Metabolic MyopathyMetabolism, Inborn ErrorsLipid Metabolism, Inborn ErrorsCarbohydrate Metabolism, Inborn ErrorsLong-Chain 3-Hydroxyacyl-CoA Dehydrogenase DeficiencyGlycogenin-1 Deficiency (Glycogen Storage Disease Type XV)Carnitine Palmitoyl Transferase 2 DeficiencyVLCAD DeficiencyMedium-chain Acyl-CoA Dehydrogenase DeficiencyMultiple Acyl-CoA Dehydrogenase DeficiencyCarnitine Transporter DeficiencyNeutral Lipid Storage DiseaseGlycogen Storage Disease Type IIGlycogen Storage Disease Type IIIGlycogen Storage Disease Type IVGlycogen Storage Disease Type VMuscle Phosphofructokinase DeficiencyPhosphoglucomutase 1 DeficiencyPhosphoglycerate Mutase DeficiencyPhosphoglycerate Kinase DeficiencyPhosphorylase Kinase DeficiencyBeta Enolase DeficiencyLactate Dehydrogenase DeficiencyGlycogen Synthase Deficiency
NCT02635269Rigshospitalet, Denmark60
招募中
不适用
Targeting the Skeletal Muscle to Treat Metabolic Dysfunction-associated Steatotic Liver DiseaseMetabolic Dysfunction-associated Steatotic Liver Disease
NCT06506513Cliniques universitaires Saint-Luc- Université Catholique de Louvain60
Unknown
不适用
Metabolomic Study of All-age CardiomyopathyLeft Ventricular Non-compactionHypertrophic CardiomyopathyArrhythmogenic Right Ventricular CardiomyopathyDilated CardiomyopathyRestrictive Cardiomyopathy
NCT03061994Beijing Institute of Heart, Lung and Blood Vessel Diseases1,000
已完成
不适用
Mechanisms of Exercise Resistance in Metabolic DiseaseImpaired Glucose Tolerance
NCT03945435Joslin Diabetes Center29
Metabolomic Approach During Exercise Testing in... | 临床试验